|
Volume 272, Number 27,
Issue of July 4, 1997
pp. 17097-17103
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
Vasoactive Peptides Modulate Vascular Endothelial Cell Growth
Factor Production and Endothelial Cell Proliferation and Invasion
(Received for publication, January 15, 1997, and in revised form, April 3, 1997)
Ali
Pedram
§
,
Mahnaz
Razandi
§
,
Ren-Ming
Hu
§¶
and
Ellis R.
Levin
§¶
From the Departments of Medicine and
¶ Pharmacology, University of California, Irvine, California 92717 and the § Department of Veterans Affairs Medical Center,
Long Beach, California 90822
The proliferation of vascular endothelial cells
(EC) is an important event in angiogenesis. The synthesis of the EC
growth factor, vascular endothelial cell growth factor (VEGF), is
stimulated by a variety of activators; but the effects of important
vasoactive peptides are not well understood, and there are no known
natural inhibitors of VEGF production. We found that the vasoactive
peptides endothelin (ET)-1 and ET-3 stimulated the synthesis of VEGF
protein 3-4-fold in cultured human vascular smooth muscle cells,
comparable in magnitude to hypoxia. ET-1 and ET-3 acted through the ETA
and ETB receptors, respectively, and signaling through protein kinase C
was important. Atrial natriuretic peptide (ANP), C-type natriuretic peptide, and C-ANP-(4-23), a ligand for the natriuretic peptide clearance receptor, equipotently inhibited production of VEGF by as
much as 88% and inhibited ET- or hypoxia-stimulated VEGF transcription. EC proliferation and invasion of matrix were stimulated by VEGF secreted into the medium by ET-incubated vascular smooth muscle
cells. This was inhibited by ANP. Our results identify the natriuretic
peptides as the first peptide inhibitors of VEGF synthesis and indicate
a novel mechanism by which vasoactive peptides could modulate
angiogenesis.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
D. Ribatti, M. T. Conconi, and G. G. Nussdorfer
Nonclassic Endogenous Novel Regulators of Angiogenesis
Pharmacol. Rev.,
June 1, 2007;
59(2):
185 - 205.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B.-Y. Bao, J. Yao, and Y.-F. Lee
1{alpha}, 25-dihydroxyvitamin D3 suppresses interleukin-8-mediated prostate cancer cell angiogenesis
Carcinogenesis,
September 1, 2006;
27(9):
1883 - 1893.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. C. Carpenter, S. Schomberg, and K. R. Stenmark
Endothelin-mediated increases in lung VEGF content promote vascular leak in young rats exposed to viral infection and hypoxia
Am J Physiol Lung Cell Mol Physiol,
December 1, 2005;
289(6):
L1075 - L1082.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. L. M. Herrera, L. R. B. Ponce, P. D. Bagamasbad, B. D. VanPelt, T. Didishvili, and N. Ruiz-Opazo
Embryonic lethality in Dear gene-deficient mice: new player in angiogenesis
Physiol Genomics,
November 17, 2005;
23(3):
257 - 268.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Zhu, S. Strada, and T. Stevens
Cyclic GMP-specific phosphodiesterase 5 regulates growth and apoptosis in pulmonary endothelial cells
Am J Physiol Lung Cell Mol Physiol,
August 1, 2005;
289(2):
L196 - L206.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Boiti, G. Guelfi, G. Brecchia, C. Dall'Aglio, P. Ceccarelli, M. Maranesi, C. Mariottini, D. Zampini, A. Gobbetti, and M. Zerani
Role of the Endothelin-1 System in the Luteolytic Process of Pseudopregnant Rabbits
Endocrinology,
March 1, 2005;
146(3):
1293 - 1300.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. R. Albig and W. P. Schiemann
Identification and Characterization of Regulator of G Protein Signaling 4 (RGS4) as a Novel Inhibitor of Tubulogenesis: RGS4 Inhibits Mitogen-activated Protein Kinases and Vascular Endothelial Growth Factor Signaling
Mol. Biol. Cell,
February 1, 2005;
16(2):
609 - 625.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Abraham, K. Krenn, G. Seebacher, P. Paulus, W. Klepetko, and S. Aharinejad
Upregulated hypoxia-inducible factor-1 DNA binding activity to the vascular endothelial growth factor-A promoter mediates increased vascular permeability in donor lung grafts
Ann. Thorac. Surg.,
May 1, 2004;
77(5):
1751 - 1755.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Wulfing, R. Diallo, C. Kersting, C. Wulfing, C. Poremba, A. Rody, R. R. Greb, W. Bocker, and L. Kiesel
Expression of Endothelin-1, Endothelin-A, and Endothelin-B Receptor in Human Breast Cancer and Correlation with Long-Term Follow-Up
Clin. Cancer Res.,
September 15, 2003;
9(11):
4125 - 4131.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Carpenter, S. Schomberg, W. Steudel, J. Ozimek, K. Colvin, K. Stenmark, and D. D. Ivy
Endothelin B Receptor Deficiency Predisposes to Pulmonary Edema Formation via Increased Lung Vascular Endothelial Cell Growth Factor Expression
Circ. Res.,
September 5, 2003;
93(5):
456 - 463.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Pedram, M. Razandi, and E. R. Levin
Deciphering Vascular Endothelial Cell Growth Factor/Vascular Permeability Factor Signaling to Vascular Permeability. INHIBITION BY ATRIAL NATRIURETIC PEPTIDE
J. Biol. Chem.,
November 8, 2002;
277(46):
44385 - 44398.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. T. Gerthoffer and C. A. Singer
Secretory Functions of Smooth Muscle: Cytokines and Growth Factors
Mol. Interv.,
November 1, 2002;
2(7):
447 - 456.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Spinella, L. Rosano, V. Di Castro, P. G. Natali, and A. Bagnato
Endothelin-1 Induces Vascular Endothelial Growth Factor by Increasing Hypoxia-inducible Factor-1alpha in Ovarian Carcinoma Cells
J. Biol. Chem.,
July 26, 2002;
277(31):
27850 - 27855.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Herrmann, P. J. Best, E. L. Ritman, D. R. Holmes Jr, L. O. Lerman, and A. Lerman
Chronic endothelin receptor antagonism prevents coronary vasa vasorum neovascularization in experimental hypercholesterolemia
J. Am. Coll. Cardiol.,
May 1, 2002;
39(9):
1555 - 1561.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Carducci, J. B. Nelson, M. Kathy Bowling, T. Rogers, M. A. Eisenberger, V. Sinibaldi, R. Donehower, T. L. Leahy, R. A. Carr, J. D. Isaacson, et al.
Atrasentan, an Endothelin-Receptor Antagonist for Refractory Adenocarcinomas: Safety and Pharmacokinetics
J. Clin. Oncol.,
April 15, 2002;
20(8):
2171 - 2180.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.A. Ghofrani, R. Wiedemann, F. Rose, N. Weissmann, R.T. Schermuly, K. Quanz, F. Grimminger, W. Seeger, and H. Olschewski
Lung cGMP release subsequent to NO inhalation in pulmonary hypertension: responders versus nonresponders
Eur. Respir. J.,
April 1, 2002;
19(4):
664 - 671.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. K. Kiemer, M. D. Lehner, T. Hartung, and A. M. Vollmar
Inhibition of Cyclooxygenase-2 by Natriuretic Peptides
Endocrinology,
March 1, 2002;
143(3):
846 - 852.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Wiedemann, H. A. Ghofrani, N. Weissmann, R. Schermuly, K. Quanz, F. Grimminger, W. Seeger, and H. Olschewski
Atrial natriuretic peptide in severe primary and nonprimary pulmonary hypertension: Response to iloprost inhalation
J. Am. Coll. Cardiol.,
October 1, 2001;
38(4):
1130 - 1136.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Bassus, O. Herkert, N. Kronemann, A. Gorlach, D. Bremerich, C. M. Kirchmaier, R. Busse, and V. B. Schini-Kerth
Thrombin Causes Vascular Endothelial Growth Factor Expression in Vascular Smooth Muscle Cells: Role of Reactive Oxygen Species
Arterioscler. Thromb. Vasc. Biol.,
September 1, 2001;
21(9):
1550 - 1555.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. M. Olfert, E. C. Breen, O. Mathieu-Costello, and P. D. Wagner
Chronic hypoxia attenuates resting and exercise-induced VEGF, flt-1, and flk-1 mRNA levels in skeletal muscle
J Appl Physiol,
April 1, 2001;
90(4):
1532 - 1538.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Pedram, M. Razandi, and E. R. Levin
Natriuretic Peptides Suppress Vascular Endothelial Cell Growth Factor Signaling to Angiogenesis
Endocrinology,
April 1, 2001;
142(4):
1578 - 1586.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
G. Egidy, L. Juillerat-Jeanneret, J.-F. Jeannin, P. Korth, F. T. Bosman, and F. Pinet
Modulation of Human Colon Tumor-Stromal Interactions by the Endothelin System
Am. J. Pathol.,
December 1, 2000;
157(6):
1863 - 1874.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Salani, V. Di Castro, M. R. Nicotra, L. Rosano, R. Tecce, A. Venuti, P. G. Natali, and A. Bagnato
Role of Endothelin-1 in Neovascularization of Ovarian Carcinoma
Am. J. Pathol.,
November 1, 2000;
157(5):
1537 - 1547.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Salani, G. Taraboletti, L. Rosano, V. Di Castro, P. Borsotti, R. Giavazzi, and A. Bagnato
Endothelin-1 Induces an Angiogenic Phenotype in Cultured Endothelial Cells and Stimulates Neovascularization In Vivo
Am. J. Pathol.,
November 1, 2000;
157(5):
1703 - 1711.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Razandi, A. Pedram, and E. R. Levin
Plasma Membrane Estrogen Receptors Signal to Antiapoptosis in Breast Cancer
Mol. Endocrinol.,
September 1, 2000;
14(9):
1434 - 1447.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
K. A. Lucas, G. M. Pitari, S. Kazerounian, I. Ruiz-Stewart, J. Park, S. Schulz, K. P. Chepenik, and S. A. Waldman
Guanylyl Cyclases and Signaling by Cyclic GMP
Pharmacol. Rev.,
September 1, 2000;
52(3):
375 - 414.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. AMANN, K. MÜNTER, S. WESSELS, J. WAGNER, V. BALAJEW, S. HERGENRÖDER, G. MALL, and E. RITZ
Endothelin A Receptor Blockade Prevents Capillary/Myocyte Mismatch in the Heart of Uremic Animals
J. Am. Soc. Nephrol.,
September 1, 2000;
11(9):
1702 - 1711.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
K. Amann, M. Buzello, A. Simonaviciene, G. Miltenberger-Miltenyi, A. Koch, A. Nabokov, M.-L. Gross, B. Gless, G. Mall, and E. Ritz
Capillary/myocyte mismatch in the heart in renal failure--a role for erythropoietin?
Nephrol. Dial. Transplant.,
July 1, 2000;
15(7):
964 - 969.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Olah and F. L. Roudabush
Down-Regulation of Vascular Endothelial Growth Factor Expression after A2A Adenosine Receptor Activation in PC12 Pheochromocytoma Cells
J. Pharmacol. Exp. Ther.,
June 1, 2000;
293(3):
779 - 787.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
N. Kronemann, A. Bouloumie, S. Bassus, C. M. Kirchmaier, R. Busse, and V. B. Schini-Kerth
Aggregating Human Platelets Stimulate Expression of Vascular Endothelial Growth Factor in Cultured Vascular Smooth Muscle Cells Through a Synergistic Effect of Transforming Growth Factor-{beta}1 and Platelet-Derived Growth FactorAB
Circulation,
August 24, 1999;
100(8):
855 - 860.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Razandi, A. Pedram, G. L. Greene, and E. R. Levin
Cell Membrane and Nuclear Estrogen Receptors (ERs) Originate from a Single Transcript: Studies of ER{alpha} and ER{beta} Expressed in Chinese Hamster Ovary Cells
Mol. Endocrinol.,
February 1, 1999;
13(2):
307 - 319.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. Bagnato, D. Salani, V. Di Castro, J. R. Wu-Wong, R. Tecce, M. R. Nicotra, A. Venuti, and P. G. Natali
Expression of Endothelin 1 and Endothelin A Receptor in Ovarian Carcinoma: Evidence for an Autocrine Role in Tumor Growth
Cancer Res.,
February 1, 1999;
59(3):
720 - 727.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N.-T. Kuo, D. Benhayon, R. J. Przybylski, R. J. Martin, and J. C. LaManna
Prolonged hypoxia increases vascular endothelial growth factor mRNA and protein in adult mouse brain
J Appl Physiol,
January 1, 1999;
86(1):
260 - 264.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T Bodamyali, C R Stevens, M E J Billingham, S Ohta, and D R Blake
Influence of hypoxia in inflammatory synovitis
Ann Rheum Dis,
December 1, 1998;
57(12):
703 - 710.
[Full Text]
|
 |
|

|
 |

|
 |
 
A. Hempel, T. Noll, C. Bach, H. M. Piper, R. Willenbrock, K. Hohnel, H. Haller, and F. C. Luft
Atrial natriuretic peptide clearance receptor participates in modulating endothelial permeability
Am J Physiol Heart Circ Physiol,
November 1, 1998;
275(5):
H1818 - H1825.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Pedram, M. Razandi, and E. R. Levin
Extracellular Signal-regulated Protein Kinase/Jun Kinase Cross-talk Underlies Vascular Endothelial Cell Growth Factor-induced Endothelial Cell Proliferation
J. Biol. Chem.,
October 9, 1998;
273(41):
26722 - 26728.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kirchengast and K. Munter
Endothelin and restenosis
Cardiovasc Res,
September 1, 1998;
39(3):
550 - 555.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Milanini, F. Vinals, J. Pouyssegur, and G. Pages
p42/p44 MAP Kinase Module Plays a Key Role in the Transcriptional Regulation of the Vascular Endothelial Growth Factor Gene in Fibroblasts
J. Biol. Chem.,
July 17, 1998;
273(29):
18165 - 18172.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Suzuma, K. Suzuma, K. Ueki, Y. Hata, E. P. Feener, G. L. King, and L. P. Aiello
Stretch-induced Retinal Vascular Endothelial Growth Factor Expression Is Mediated by Phosphatidylinositol 3-Kinase and Protein Kinase C (PKC)-zeta but Not by Stretch-induced ERK1/2, Akt, Ras, or Classical/Novel PKC Pathways
J. Biol. Chem.,
January 4, 2002;
277(2):
1047 - 1057.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1997 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|